What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Ulrike Peters mostly deals with Genome-wide association study, Genetics, Internal medicine, Single-nucleotide polymorphism and Genetic association.
Her Genome-wide association study research includes elements of Case-control study, Allele, Locus and Genetic architecture.
Her work in Genetics addresses subjects such as Meta-analysis, which are connected to disciplines such as FTO gene and Body mass index.
Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology.
Her Genetic association research incorporates themes from Quantitative trait locus, Allele frequency and Genomics.
Her Cancer study combines topics in areas such as Gastroenterology and Risk factor.
Her most cited work include:
- Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (212 citations)
- Genome-wide physical activity interactions in adiposity. A meta-analysis of 200,452 adults (211 citations)
- Genetic analyses of diverse populations improves discovery for complex traits (209 citations)
What are the main themes of her work throughout her whole career to date?
Ulrike Peters mainly focuses on Internal medicine, Colorectal cancer, Oncology, Genome-wide association study and Single-nucleotide polymorphism.
Internal medicine is closely attributed to Endocrinology in her research.
Her Colorectal cancer research is multidisciplinary, incorporating perspectives in Gastroenterology, Lower risk, Adenoma and Hazard ratio.
Her study in Oncology is interdisciplinary in nature, drawing from both Body mass index, Epidemiology, Prospective cohort study, Proportional hazards model and Breast cancer.
Her Genome-wide association study study deals with Genetic association intersecting with Allele frequency.
The various areas that Ulrike Peters examines in her Odds ratio study include Mendelian randomization and Confidence interval.
She most often published in these fields:
- Internal medicine (78.24%)
- Colorectal cancer (59.95%)
- Oncology (55.32%)
What were the highlights of her more recent work (between 2017-2021)?
- Colorectal cancer (59.95%)
- Internal medicine (78.24%)
- Oncology (55.32%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Colorectal cancer, Internal medicine, Oncology, Genome-wide association study and Cancer.
Her Colorectal cancer research includes themes of Cancer research, Epidemiology, Microsatellite instability, Genotype and Aspirin.
Her research integrates issues of Cohort study, Confidence interval, KRAS, Single-nucleotide polymorphism and Cohort in her study of Oncology.
Her Genome-wide association study study necessitates a more in-depth grasp of Genetics.
Her study in Cancer is interdisciplinary in nature, drawing from both Red meat and Family medicine.
The Odds ratio study combines topics in areas such as Mendelian randomization and Case-control study.
Between 2017 and 2021, her most popular works were:
- Genetic analyses of diverse populations improves discovery for complex traits (209 citations)
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer (178 citations)
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer (178 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Ulrike Peters mainly focuses on Internal medicine, Genome-wide association study, Colorectal cancer, Oncology and Cancer.
Her Genome-wide association study research is multidisciplinary, relying on both Disease, Genetic association and Genetic architecture.
Ulrike Peters has researched Colorectal cancer in several fields, including Cancer research, Wnt signaling pathway, DNA methylation, Meta-analysis and Genotype.
Her Oncology research incorporates elements of Odds ratio, Breast cancer, Carcinoma and Allele.
Her Odds ratio study integrates concerns from other disciplines, such as Mendelian randomization and Case-control study.
Her Cancer research is multidisciplinary, incorporating elements of Early detection, Epidemiology, Family medicine and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
